| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.36 | 0.02 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.03 |